Neurologists of the Valencian community gathered in Denia to study the management of advanced Parkinson’s disease.
– approximately 150,000 people in Spain (1) suffering from Parkinson’s disease, and are estimated more than 15,000 cases in the Valencian Community
-one of every five patients is less than 50 years old (2)
Denia, June 2012.- the Valencian society of Neurology, with the collaboration of Abbott, held last Friday in Denia a scientific meeting under the title Management of the patient with Parkinson’s disease advanced Duodopa. The meeting, which was held in the Hotel Las Rotas of Denia, Servius to improve assistance to patients with this disease in their more advanced through the use of this treatment. It also included a review of clinical cases to expose the practical application of this treatment in patients candidates to receive it.
Dr. Carlos Leiva, the Neurology service of the General Hospital of Alicante, said: the meeting has served to update knowledge about treatment with Duodopa disease advanced Parkinson’s disease and to improve the expertise in the application of the treatment patients candidates to receive it, through the correct protocol to do so. For the success of treatment Duodopa, in addition to the performance of the neurologist, it is necessary to have a multidisciplinary team coordinated, as reflected in the composition of the rapporteurs.
The symptoms that causes Parkinson’s disease, and that they often limit the quality of life of patients, include those affecting the movement (tremor at rest, numbness, hipocinesia or postural instability) and which do not affect the motor unit (anxiety, depression, impaired memory, slow thoughts or pain).
Not all symptoms develop in all patients, and depend on both the evolution of pathology in every person and treatment that have been used (3).
About Parkinson’s disease
Parkinson disease (PD) is a disease that affects the nervous system in the area responsible for coordinating activity, muscle tone and movements. Estimated affecting 150,000 people in Spain (1). This neurodegenerative disorder, the second most frequent, is of unknown cause and chronic and progressive course.
The EP is manifested when cells in the area of the brain, called substantia nigra ”, begin to malfunction and die. These cells are responsible for producing a substance called dopamine ”. Dopamine is a neurotransmitter, or chemical Messenger, that sends information to the brain areas that control movement (4) and coordination. In patients of EP, the dopamine-producing cells begin to die, resulting in the reduction of the neurotransmitter.
About of the Valencian society of Neurology
The Valencian society of Neurology, founded in 1985, is for the rational promotion of Neurology within its territorial scope, including neurological assistance, postgraduate medical and training of specialists in neurology, publications and research, advising health authorities and the representation of all its partners in the administration. integrates to most of the neurologists who provide services in public health valenciana (Valencian health agency), as well as those who do so in other health areas.
About Abbott
Abbott is a biomedical company that is dedicated to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, which include health, nutritional products and diagnostic. The company employs approximately 91,000 people worldwide and markets its products in more than 130 countries.
Abbott is certified as Top Employers 2011 by CRF Institute, and as the best company to work in the health sector and the second in the general ranking of sectors according to Best Workplaces Spain 2010. Abbott has over 1,500 employees and 61 years of history in our country. The company’s activity is aimed at meeting the needs of patients with chronic diseases and high clinical, economic, social, and emotional impact.
Abbott has presence in all areas of the Spanish healthcare industry (including r & d and manufacturing at its centres in Madrid, Granada and Alcobendas). Its products cover all phases of the process of the disease (prevention, diagnosis, treatment and healing) and are present in every moment of the life cycle: newborn, childhood, adolescence, maturity and old age.
Abbott’s news releases are available on the company’s web pages: www.abbott.com and www.abbott.es.
–
Referencia:
(1) Federación Española de Parkinson: 2010 activity report.
(2) Federación Española de Parkinson.
(3) Federación Española de Parkinson: common symptoms.
(4) Federación Española de Parkinson: what is Parkinson’s disease?.
